News | Computed Radiography (CR) | November 23, 2015

CIRS Whole Body and Organ Dose Phantoms for Radiation Therapy

dosimetry phantoms

CIRS ATOM phantoms are a full line of anthropomorphic, cross sectional dosimetry phantoms designed to investigate organ dose, whole body effective dose as well as verification of delivery of therapeutic radiation doses.

ATOM is the only line of dosimetry phantoms to range in sizes from newborn to adult. Six models are available: newborn, 1-year, 5-year and 10-year old pediatric phantoms as well as adult male and female phantoms.

Each phantom is sectional in design with traditional 25 mm thick sections. The sectional surfaces are extremely flat and smooth and do not require any special coatings or treatment. This results in minimal interfaces between the slabs when viewed in a scout or projection X-ray. The ATOM line also differs from other dosimetry phantoms by providing optimized TLD locations specific to 21 inner organs.

Tissue-equivalent epoxy resins are used in all aspects of the phantom. CIRS technology offers superior tissue simulation Dosimetry Verification Phantoms by covering a wider range of energy levels from diagnostic to therapeutic. In addition, all bones are homogeneous and are formulated to represent age appropriate, average bone composition. CIRS bone formulations offer distinct advantages over natural skeletons and other types of simulated bone. 

  • Phantom models cover a wide range of patient ages
  • Organ specific dosimetry with minimal detectors
  • Superior tissue simulation and lifelike imaging properties
  • Homogeneous bone
  • Accommodates wide variety of detectors
  • Age appropriate references

This product or an optional accessory of this product requires a CIRS dosimetry cavity code before an order can be placed. Please refer to the Dosimetry Cavity Codes document to identify the CIRS code for the probe you intend to use with this product.

For more information: www.cirsinc.com

Related Content

RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...